• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与皮下植入式除颤器引入相关的学习曲线。

The learning curve associated with the introduction of the subcutaneous implantable defibrillator.

作者信息

Knops Reinoud E, Brouwer Tom F, Barr Craig S, Theuns Dominic A, Boersma Lucas, Weiss Raul, Neuzil Petr, Scholten Marcoen, Lambiase Pier D, Leon Angel R, Hood Margaret, Jones Paul W, Wold Nicholas, Grace Andrew A, Olde Nordkamp Louise R A, Burke Martin C

机构信息

Academic Medical Center, Amsterdam, The Netherlands.

Academic Medical Center, Amsterdam, The Netherlands

出版信息

Europace. 2016 Jul;18(7):1010-5. doi: 10.1093/europace/euv299. Epub 2015 Aug 31.

DOI:10.1093/europace/euv299
PMID:26324840
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4927061/
Abstract

AIMS

The subcutaneous implantable cardioverter defibrillator (S-ICD) was introduced to overcome complications related to transvenous leads. Adoption of the S-ICD requires implanters to learn a new implantation technique. The aim of this study was to assess the learning curve for S-ICD implanters with respect to implant-related complications, procedure time, and inappropriate shocks (IASs).

METHODS AND RESULTS

In a pooled cohort from two clinical S-ICD databases, the IDE Trial and the EFFORTLESS Registry, complications, IASs at 180 days follow-up and implant procedure duration were assessed. Patients were grouped in quartiles based on experience of the implanter and Kaplan-Meier estimates of complication and IAS rates were calculated. A total of 882 patients implanted in 61 centres by 107 implanters with a median of 4 implants (IQR 1,8) were analysed. There were a total of 59 patients with complications and 48 patients with IAS. The complication rate decreased significantly from 9.8% in Quartile 1 (least experience) to 5.4% in Quartile 4 (most experience) (P = 0.02) and non-significantly for IAS from 7.9 to 4.8% (P = 0.10). Multivariable analysis demonstrated a hazard ratio of 0.78 (P = 0.045) for complications and 1.01 (P = 0.958) for IAS. Dual-zone programming increased with experience of the individual implanter (P < 0.001), which reduced IAS significantly in the multivariable model (HR 0.44, P = 0.01). Procedure time decreased from 75 to 65 min (P < 0.001). The complication rate and procedure time stabilized after Quartile 2 (>13 implants).

CONCLUSION

There is a short and significant learning curve associated with physicians adopting the S-ICD. Performance stabilizes after 13 implants.

摘要

目的

皮下植入式心律转复除颤器(S-ICD)的引入是为了克服与经静脉导线相关的并发症。采用S-ICD要求植入者学习一种新的植入技术。本研究的目的是评估S-ICD植入者在植入相关并发症、手术时间和不适当电击(IAS)方面的学习曲线。

方法与结果

在来自两个临床S-ICD数据库(IDE试验和EFFORTLESS注册研究)的汇总队列中,评估了并发症、180天随访时的IAS以及植入手术持续时间。根据植入者的经验将患者分为四分位数,并计算并发症和IAS发生率的Kaplan-Meier估计值。对107名植入者在61个中心植入的882例患者进行了分析,植入者的植入中位数为4例(四分位间距1,8)。共有59例患者出现并发症,48例患者发生IAS。并发症发生率从第一四分位数(经验最少)的9.8%显著降至第四四分位数(经验最多)的5.4%(P = 0.02),而IAS发生率从7.9%降至4.8%,差异无统计学意义(P = 0.10)。多变量分析显示,并发症的风险比为0.78(P = 0.045),IAS的风险比为1.01(P = 0.958)。双区程控随着植入者个人经验的增加而增加(P < 0.001),在多变量模型中显著降低了IAS(风险比0.44,P = 0.01)。手术时间从75分钟降至65分钟(P < 0.001)。第二四分位数(>13次植入)后并发症发生率和手术时间趋于稳定。

结论

医生采用S-ICD存在一个短暂且显著的学习曲线。植入13次后性能趋于稳定。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/437d/4927061/1abf8c7ef95b/euv29903.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/437d/4927061/d5709ae70110/euv29901.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/437d/4927061/3bbb55d54016/euv29902.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/437d/4927061/1abf8c7ef95b/euv29903.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/437d/4927061/d5709ae70110/euv29901.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/437d/4927061/3bbb55d54016/euv29902.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/437d/4927061/1abf8c7ef95b/euv29903.jpg

相似文献

1
The learning curve associated with the introduction of the subcutaneous implantable defibrillator.与皮下植入式除颤器引入相关的学习曲线。
Europace. 2016 Jul;18(7):1010-5. doi: 10.1093/europace/euv299. Epub 2015 Aug 31.
2
Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies.SIMPLE 和 EFFORTLESS 研究中皮下植入式和经静脉植入式心脏复律除颤器治疗的倾向评分匹配比较。
Europace. 2018 Sep 1;20(FI2):f240-f248. doi: 10.1093/europace/euy083.
3
Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT).多中心自动除颤器植入试验-降低不适当治疗(MADIT-RIT)中与植入式心脏复律除颤器编程相关的死亡率。
Circ Arrhythm Electrophysiol. 2014 Oct;7(5):785-92. doi: 10.1161/CIRCEP.114.001623. Epub 2014 Aug 18.
4
Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry: The EFFORTLESS Study.皮下植入式心脏复律除颤器注册研究的植入和中期结果:EFFORTLESS 研究。
J Am Coll Cardiol. 2017 Aug 15;70(7):830-841. doi: 10.1016/j.jacc.2017.06.040.
5
Long-Term Clinical Outcomes of Subcutaneous Versus Transvenous Implantable Defibrillator Therapy.皮下与经静脉植入式除颤器治疗的长期临床结果。
J Am Coll Cardiol. 2016 Nov 8;68(19):2047-2055. doi: 10.1016/j.jacc.2016.08.044.
6
Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-Year Results From a Pooled Analysis of the IDE Study and EFFORTLESS Registry.完全皮下植入式除颤器的安全性和有效性:IDE 研究和 EFFORTLESS 注册研究的汇总分析 2 年结果。
J Am Coll Cardiol. 2015 Apr 28;65(16):1605-1615. doi: 10.1016/j.jacc.2015.02.047.
7
Use of a discrimination algorithm to reduce inappropriate shocks with a subcutaneous implantable cardioverter-defibrillator.使用一种鉴别算法来减少皮下植入式心脏复律除颤器的不适当电击。
Heart Rhythm. 2014 Aug;11(8):1352-8. doi: 10.1016/j.hrthm.2014.04.012. Epub 2014 Apr 13.
8
Incidence, implications, and management of sense-B-noise failure in subcutaneous cardioverter-defibrillator patients: insights from a large multicentre registry.皮下植入式心律转复除颤器患者感知噪声失败的发生率、影响及处理:来自大型多中心注册研究的启示。
Europace. 2024 Jun 3;26(6). doi: 10.1093/europace/euae161.
9
Predictors of short-term complications after implantable cardioverter-defibrillator replacement: results from the Ontario ICD Database.植入型心律转复除颤器更换术后短期并发症的预测因素:安大略省 ICD 数据库的结果。
Circ Arrhythm Electrophysiol. 2011 Apr;4(2):136-42. doi: 10.1161/CIRCEP.110.959791. Epub 2011 Feb 15.
10
Peri-procedural routines, implantation techniques, and procedure-related complications in patients undergoing implantation of subcutaneous or transvenous automatic cardioverter-defibrillators: results of the European Snapshot Survey on S-ICD Implantation (ESSS-SICDI).接受皮下或经静脉自动心脏除颤器植入术患者的围手术期常规、植入技术和与手术相关的并发症:欧洲皮下 ICD 植入术快照调查(ESSS-SICDI)的结果。
Europace. 2018 Jul 1;20(7):1218-1224. doi: 10.1093/europace/euy092.

引用本文的文献

1
Device-Related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-Term Follow-Up: The PRAETORIAN-XL Trial.长期随访期间经静脉与皮下植入式心律转复除颤器治疗的器械相关并发症:PRAETORIAN-XL试验
Circulation. 2025 Jul 22;152(3):172-182. doi: 10.1161/CIRCULATIONAHA.125.074576. Epub 2025 Apr 25.
2
Long-Term Complications Related to Cardiac Implantable Electronic Devices.与心脏植入式电子设备相关的长期并发症
J Clin Med. 2025 Mar 18;14(6):2058. doi: 10.3390/jcm14062058.
3
Elective Generator Replacement of the Subcutaneous Implantable Defibrillator-Always a Simple Pit Stop?

本文引用的文献

1
Inappropriate shocks in the subcutaneous ICD: Incidence, predictors and management.皮下植入式心律转复除颤器(ICD)的不适当电击:发生率、预测因素及处理
Int J Cardiol. 2015 Sep 15;195:126-33. doi: 10.1016/j.ijcard.2015.05.135. Epub 2015 May 22.
2
Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-Year Results From a Pooled Analysis of the IDE Study and EFFORTLESS Registry.完全皮下植入式除颤器的安全性和有效性:IDE 研究和 EFFORTLESS 注册研究的汇总分析 2 年结果。
J Am Coll Cardiol. 2015 Apr 28;65(16):1605-1615. doi: 10.1016/j.jacc.2015.02.047.
3
A new algorithm to reduce inappropriate therapy in the S-ICD system.
皮下植入式除颤器的择期发生器更换——总是一个简单的短暂停留吗?
J Cardiovasc Electrophysiol. 2025 May;36(5):1053-1060. doi: 10.1111/jce.16638. Epub 2025 Mar 20.
4
Effect of Metrics-Based Simulation Training to Proficiency on Procedure Quality and Errors Among Novice Cardiac Device Implanters: The IMPROF Randomized Trial.基于指标的模拟训练对新手心脏设备植入者程序质量和错误的熟练程度的影响:IMPROF 随机试验。
JAMA Netw Open. 2023 Aug 1;6(8):e2322750. doi: 10.1001/jamanetworkopen.2023.22750.
5
Subcutaneous Implantable Cardioverter Defibrillator: A Contemporary Overview.皮下植入式心律转复除颤器:当代概述。
Life (Basel). 2023 Jul 28;13(8):1652. doi: 10.3390/life13081652.
6
Real-world evidence for the use of subcutaneous implantable cardioverter-defibrillators in China: A single-center experience.中国皮下植入式心律转复除颤器应用的真实世界证据:单中心经验。
Herz. 2023 Dec;48(6):462-469. doi: 10.1007/s00059-023-05192-4. Epub 2023 Aug 4.
7
Successful defibrillation testing in patients undergoing elective subcutaneous implantable cardioverter-defibrillator generator replacement.在接受选择性皮下植入式心律转复除颤器(ICD)发生器更换的患者中成功进行除颤测试。
Europace. 2023 Jul 4;25(7). doi: 10.1093/europace/euad184.
8
Procedure, management, and outcome of subcutaneous implantable cardioverter-defibrillator extraction in clinical practice.在临床实践中皮下植入式心律转复除颤器取出术的程序、管理和结果。
Europace. 2023 Jun 2;25(6). doi: 10.1093/europace/euad158.
9
Reduction in inappropriate therapies through device programming in subcutaneous implantable defibrillator patients: data from clinical practice.通过皮下植入式除颤器患者的设备程控减少不适当治疗:来自临床实践的数据。
Europace. 2023 May 19;25(5). doi: 10.1093/europace/euac234.
10
Intermuscular technique for implantation of the subcutaneous implantable defibrillator: a propensity-matched case-control study.经肌内入路植入皮下埋藏式除颤器的技术:一项倾向评分匹配的病例对照研究。
Europace. 2023 Apr 15;25(4):1423-1431. doi: 10.1093/europace/euad028.
一种减少皮下植入式心律转复除颤器(S-ICD)系统中不适当治疗的新算法。
J Cardiovasc Electrophysiol. 2015 Apr;26(4):417-423. doi: 10.1111/jce.12612. Epub 2015 Feb 17.
4
Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.瑞典植入式电子设备的使用现状:来自瑞典起搏器和植入式心脏复律除颤器注册中心的数据。
Europace. 2015 Jan;17(1):69-77. doi: 10.1093/europace/euu233. Epub 2014 Oct 21.
5
Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry.全球完全皮下植入式除颤器的经验:来自EFFORTLESS S-ICD注册研究的早期结果。
Eur Heart J. 2014 Jul 1;35(25):1657-65. doi: 10.1093/eurheartj/ehu112. Epub 2014 Mar 26.
6
Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark.心脏植入式电子设备植入后的并发症:丹麦全国完整队列分析
Eur Heart J. 2014 May;35(18):1186-94. doi: 10.1093/eurheartj/eht511. Epub 2013 Dec 17.
7
Inappropriate subcutaneous implantable cardioverter-defibrillator shocks due to T-wave oversensing can be prevented: implications for management.因T波过度感知导致的不适当皮下植入式心律转复除颤器电击可被预防:对管理的启示
Heart Rhythm. 2014 Mar;11(3):426-34. doi: 10.1016/j.hrthm.2013.12.007. Epub 2013 Dec 7.
8
Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator.完全皮下植入式心脏除颤器的安全性和有效性。
Circulation. 2013 Aug 27;128(9):944-53. doi: 10.1161/CIRCULATIONAHA.113.003042.
9
Two-incision technique for implantation of the subcutaneous implantable cardioverter-defibrillator.两切口技术在皮下植入式心律转复除颤器中的应用。
Heart Rhythm. 2013 Aug;10(8):1240-3. doi: 10.1016/j.hrthm.2013.05.016. Epub 2013 May 21.
10
The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort.完全皮下植入式心脏除颤器:荷兰大型队列的初步临床经验。
J Am Coll Cardiol. 2012 Nov 6;60(19):1933-9. doi: 10.1016/j.jacc.2012.06.053. Epub 2012 Oct 10.